By use of crossed immunoelectrophoresis techniques, respiratory syncytial (RS) virus-specific precipitates were produced between RS virus cellular antigen [solubilized in tris(hydroxymethyl)aminomethane-glycine buffer, pH 9] and antiserum raised in rabbits against semipurified RS virus. When these precipitates were employed as antigens for further immunizations in rabbits, antibodies (anti-RSV-precip.I) were produced which reacted with only one RS virus antigen when tested by the crossed immunoelectrophoresis technique. Precipitates obtained between RS virus cellular antigen (labeled with L-[tS]methionine) and anti-RSVprecip.I were examined by polyacrylamide gel electrophoresis, which showed that anti-RSV-precip.I precipitated RS virus polypeptides of molecular weights 28,000 to 84,000. Anti-RSV-precip.I was employed as capture antibodies in the enzymelinked immunosorbent assay, in which RS virus cellular antigen was used as the second layer. Determination of human RS virus immunoglobulin G antibodies by this enzyme-linked immunosorbent assay technique showed a high degree of sensitivity, specificity, and reproducibility.
The introduction of new sensitive enzyme immunoassays (2, 17) into diagnostic virology has created a demand for more potent and more specific immune sera. The purpose ofthe present report is to describe the production of antiserum to respiratory syncytial (RS) virus polypeptides (molecular weight [MW] , 28 ,000 to 84,000) by the use of crossed immunoelectrophoresis (CIEP) techniques. Further characterization of this antiserum and a brief summary of results obtained with it in the enzyme-linked immunosorbent assay (ELISA) will also be presented.
RS virus is a single-stranded ribonucleic acid virus belonging to the family Paramyxoviridae (14) . Multiplication occurs in the cytoplasm of the host cell, independent of cellular deoxyribonucleic acid (11) , with maturation taking place by budding from altered plasma membranes (16) . Previous reports have shown that six to eight RS virus polypeptides (MW ranging from 20,000 to 80,000) can be demonstrated in RS virions or in RS virus-infected cells by polyacrylamide gel electrophoresis (PAGE) (4, 5, 13, 18, 24, 32) . According to a recent World Health Organization report, RS virus is the most important respiratory disease pathogen of infants and young children (31) .
It is difficult to produce RS virions or RS viral antigens free of host cell material. CIEP techniques (30) facilitate the purification of viral antigens, as shown by previous reports from this laboratory (8, 9, 12, 25) . The immunization of rabbits with precipitates (consisting of rabbit antisera and viral antigens) obtained by CIEP techniques has made it possible to produce specific antisera to several herpes simplex virus (HSV) antigens (27) as well as to rotavirus (8) and influenza virus antigens (12) .
MATERLALS AND METHODS
Cell culture. Vero and HEp-2 cells were grown in Roux bottles with Eagle minimal essential medium (Earles salt solution) and 10% fetal bovine serum and maintained in the same medium with 2% fetal bovine serum. For isolation of RS virus from specimens of nasopharyngeal secretions from patients with acute respiratory disease, HEp-2 cells were grown in plastic tubes (12 by 100 mm; Nunc, Denmark).
RS virus strain. The Long strain of RS virus, passed approximately 5 times in KB cells and approximately 55 times in HEp-2 cells, was used in these studies.
Titration of RS virus. Virus titration was done by plaque titration in Vero cell monolayers in 2.5-cm petri dishes. RS virus was passed twice in Vero cell cultures (Roux bottles), and tissue culture maintenance medium was harvested from cultures showing 3+ cytopathic effect. The maintenance medium was clarified by low-speed centrifugation and supplemented with bovine serum albumin (final concentration, 0.1%) before being stored in small volumes at -70°C. Virus diluted in tissue culture maintenance medium was absorbed for 2 h (at 35°C in a C02 incubator). After removal of the rest of the inoculum from the petri dishes, Leibovitz L-15 medium containing 10% fetal bovine serum and 0.8% agarose (19) was overlaid. After 5 days of incubation at 35°C without C02, the monolayers were fixed with 100% methyl alcohol for 10 min, stained with methylene blue (1%, wt/vol, in distilled water) for 30 min after removal of the overlay, and destained for 5 min with 96% ethyl alcohol.
Titration of RS virus neutralizing antibodies. Antibody titration was done by plaque reduction tests. Vero cell culture maintenance medium containing approximately 100 plaque-forming units per 0.3 ml was incubated with equal volumes of the serum dilutions at room temperature. After 1 h, 0.6 ml of these mixtures was added to each Vero cell monolayer (in 2.5-cm petri dishes) and incubated for 2 h in a C02 incubator at 37°C before the rest of the inoculum was removed and the Leibovitz-agarose overlay described above was added. The titer was read after 5 days of incubation at 35°C without C02 and calculated as the highest serum dilution giving more than 50% reduction of the plaque-forming unit count when compared with control dishes without serum.
Production of antiserum to gradient-purified RS virus. One-liter volumes of tissue culture maintenance medium from RS virus-infected HEp-2 cell monolayers in Roux bottles (showing 3+ cytopathic effect) were treated according to the method described by Senterfit and Baldridge (22) . After precipitation with polyethylene glycol (PEG 6,000), the resuspended sediment was ultracentrifuged (26,000 rpm) for 16 Electron microscopy. Estimation of the number of RS virions was made according to the method described by Pyrhonen (20) . Volumes (10,l) (8, 25, 30) . Details regarding the exact experimental conditions are given in the figure legends.
Immunization of rabbits with agarose gel precipitate produced by CIEP. RSV precipitate I (shown in Fig. 1A ) was used as the antigen. Each rabbit was immunized intracutaneously three times (with three precipitates each time) at intervals of 10 days and bled 10 days after the last immunization, as described earlier (12, 26 (25 ml) . RS virus cellular antigen was produced from this mixture of labeled and unlabeled cells as described above. The media from the labeled and unlabeled bottles were mixed, and RS virus was purified from this mixture as described below.
Purification of L-[5S]methionine-labeled RS virus. The mixture of tissue culture maintenance media referred to above was clarified (3,000 x g, 30 min, 4°C), and 25 showing maximum counts per minute and a specific gravity of 1.21 g/ml) was diluted up to 4 ml in PBS containing 1% of the protein inhibitor aprotinin (Midran, Novo Industries, Copenhagen, Denmark) and centrifuged for 1 h at 55,000 x g (SW60 rotor) at 4°C. The sediment was suspended in 50 pl of electrophoresis sample buffer (12) containing 2% aprotinin before being tested by analytical sodium dodecyl sulfate (SDS)-PAGE as described below.
SDS-PAGE. Analytical SDS-PAGE of solubilized samples of purified RS virus and of solubilized gel precipitates was carried out in vertical slab gels as described previously (12) , with the following modifications: the thickness of the gel was 1.5 mm, the stacking gel contained 4% (wt/vol) acrylamide, and the separation gel contained 10% (wt/vol) acrylamide. The sample buffer was supplemented with 2% (wt/ vol) aprotinin; the electrophoresis was carried out for 260 min with a constant current of 40 mA. Autoradiography was carried out at -70°C for 2 weeks with Kodak XRY-1 film.
Preparation of the immunoglobulin fraction from rabbit antisera and from human sera. Immunoglobulin fractions were obtained by the method described by Harboe and Ingild (10) .
Determination of concentrations of immunoglobulin solutions. Immunoglobulin concentrations were determined by the method described by Bramhall et al. (3) .
Examination of nasopharyngeal secretions from children for cells containing RS virus antigen. Nasopharyngeal secretions were examined by the methods outlined by Gardner and McQuillin (6) . Washed cells fixed on ordinary microscope slides were incubated with anti-RS serum (bovine serum; Wellcome Research Laboratories, Beckenham, England) at 37°C for 1 h, followed by incubation (also at 37°C) for 45 min with fluorescein isothiocyanate-conjugated rabbit anti-bovine serum (Wellcome).
ELISA employed. Determination of IgG antibodies in human sera was performed on polystyrene microtest plates (A/S Nunc, Denmark; code no. 2-62162) by employing the following reagents: (i) rabbit anti-RS virus precipitate I serum (anti-RSV-precip.I; see below), immunoglobulin fraction containing 35 mg of immunoglobulin per ml; (ii) RS virus cellular antigen (or control antigen) harvested in Tris-glycine buffer (pH 9) as described above; (iii) rabbit antihuman IgG, peroxidase conjugated (DAKO Immunoglobulins A/S; code no. P1090); (iv) bicarbonate buffer (pH 9.6) (15 mM Na2CO3, 35 mM NaHCO3, 3 mM NaN3); (v) washing solution (pH 7.2) (0.5 M NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 6.5 mM .JU2HPO4.2H20, and 0.5 ml of Tween-20 added per 1,000 ml); (vi) dilution buffer (pH 7.2) (same as washing solution, with 5 g of bovine albumin [Sigma A8022, fraction V] and 10 ml of phenol red [0.1%, wt/vol] added per 1,000 ml); (vii) staining solution (pH 5) (34.7 mM citric acid, 66.7 mM Na2HPO4.2H20, 500 mg of 1,2-phenylenediamine-dihydrochloride [Fluka] , and 500 pl of 30% H202 added per 1,000 ml). Serum dilutions of 1:100, 1:400, 1:1,600, and 1:6,400 were examined by the following procedure utiizing the reagents described above. Titration of CF RS virus antibodies. Complement-fixing (CF) antibody titration was done at the State Serum Institute in Copenhagen (by C. Mordhorst) according to a method described earlier (15) . The antigen employed was made from RS virus (Long strain)-infected GMK cell cultures.
HSV type 1 reference antigen and antiserum against HSV antigen no. 11. Reference antigen was prepared from Triton X-100-solubiized rabbit cornea cells as described earlier (25, 27) . Antiserum against the glycoprotein, antigen no. 11, was raised in rabbits as described earlier (27, 29) .
RESULTS
Production of immunoprecipitates by CIEP between antibodies to semipurified RS virus (anti-RSV-prim) and RS virus antigen. Figure 1 (A and B) shows the results of CIEP in which anti-RSV-prim was employed in both plates in the second-dimension gel. RS virus antigen was employed in the first-dimension gel in Fig. 1A , and control antigen was employed in Fig. lB .
The antibodies used in these plates were adsorbed with HEp-2 cells before use (6 x 107 cells per ml of serum for 18 h at 4°C). The antigens used were cellular antigens sonicated in Trisglycine buffer as outlined above. In this figure and in Fig. 2 an empty gel (without antigen or serum) was interposed between the first-and second-dimension gels to improve the precipitate patterns.
The precipitate marked RSV-precip.I, which could be found only in the RS antigen plate, was used for further immunization. This precipitate was cut out of the wet gel, and several immunizations with precipitates were given intracutaneously to rabbits as described above. The antiserum obtained by this procedure is called anti-RSV-precip.I.
Characterization of rabbit anti-RSV-precip.I. (i) Lack of reaction with RS virus glycoproteins in CIEP. Figure 2 shows the precipitate obtained by CIEP, with the same antigen as in Fig. 1 in the first-dimension gel and with anti-RSV-precip.I antibodies in the seconddimension gel; the immunoglobulin fraction was adjusted to a concentration of approximately 30 g/liter. Figure 2B is analogous to Fig. 2A , except that the lectin concanavalin A (ConA) was incorporated in the first-dimension gel. ConA was employed at a concentration known to absorb virus antigens of glycoprotein nature (12, 28) . The similarity of the precipitates in Fig. 2A Fig.  2A ). This precipitate was removed in Fig. 2B 20 g/liter in 0.15 M NaCl) per cm2. The anionic detergent Triton X-100 was added at 0.5% (vol/vol) to both the gel buffer and the electrophoresis buffer to facilitate the precipitation of the HSV antigen. Experimental conditions were otherwise as described for Fig. 1. (B) This gel is analogous to that in (A) except that ConA (60 pg/cm2) was incorporated in the first-dimension gel.
tive control in the experiment.
(ii) The immunogenic potency in human RS virus infection of the precipitated antigen. The anti-RSV-precip.I immunoglobulins were produced for diagnostic purposes. It was therefore important to know whether antibodies to the antigen precipitated out by CIEP with rabbit antibodies (as in Fig. 2A) were also produced in human infections. This question was evaluated by the CIEP-intermediate gel technique (1).
In Fig. 3 the same antibodies and antigen were employed as in Fig. 2A. In Fig. 3A the intermediate gel is empty; in Fig. 3B and C the immu- ples without antibodies to RS virus (checked by CF, IF, and ELISA techniques). In Fig. 3C the immunoglobulin fraction added to the intermediate gel was prepared from a pool of 10 human serum samples with intermediate to high antibody titers to virus. The immunoglobulin concentrations of these pools were adjusted to approximately 10 g/liter. All 20 sera were from children (1 to 3 years old) with lower respiratory disease (pneumonitis or bronchitis). A comparison of Fig. 3A and Fig. 3C reveals that the antigen migration was inhibited in the intermediate gel in Fig. 3C (containing human antibodies to RS virus), whereas no inhibition was seen in Fig. 3B . These findings strongly indicate that the antigens reacting in precipitation with rabbit anti-RSV-precip.I antibodies are also immunogenic during RS virus infections in children.
(iii) Antibody titers measured by plaque neutralization and IF technique. When the immunoglobulin fraction (30 g/liter) from anti-RSV-precip.I serum was tested by plaque reduction in Vero cell monolayers, the titer was found to be less than 1:50. For comparison, the positive and negative human serum pools (described above) showed plaque reduction titers of approximately 1:3,200 and less than 1:50, respectively.
The titer of the immunoglobulin fraction of anti-RSV-precip.I serum (30 g/liter) determined by the IF technique was 1:320, whereas the immunoglobulin fractions of the positive and negative human serum pools (10 g/liter) were 1: 160 and less than 1:10, respectively. Anti-RSVprecip.I antibodies gave a fine granular cytoplasmic fluorescence in the HEp-2 cells used in the IF assay. Fig. 4 were cut out of the wet gel and solubilized in SDS-containing Tris buffer before being tested. Anti-RSV-precip.I did not produce precipitates with cellular antigen produced from uninfected control HEp-2 cell cultures. Therefore precipitates produced with control antigen from L- [35S] methionine-labeled control cultures could not be tested. The gels were calibrated with a mixture of six proteins (MW 14,400 to 94,000) run at the same time (12) . Figure 5 shows autoradiography of solubilized RS virus (track c). The samples, which were layered on the gel corresponding to (24) advocated that RS virus precipitated by PEG 6,000 should be filtered through a Bio-Rad Biogel A 15-m column before further purification on sucrose gradients. This author (24) found (by PAGE) seven RS virus polypeptides of MW 25,000 to 75,000.
In the present paper, Tris-glycine buffer without detergent was employed for the preparation of the antigen used in CIEP techniques. When ConA was added to the first-dimension gel in CIEP, no inhibiting effect was observed on the antigens precipitated by anti-RSV-precip.I but ConA did inhibit the precipitation of HSV antigen no. 11, which was included in the same plate as a positive control. This antigen is a glycoprotein, according to earlier findings (27) . Furthermore, anti-RSV-precip.I did not neutralize RS virus when assayed in plaque-reduction tests. These findings do not support the possibility that anti-RSV-precip.I is able to react with RS virus surface glycoproteins.
Levine (13) and Peeples and Levine (18) examined RS virus polypeptides by different PAGE techniques and showed that the migration of the glycoproteins in the discontinuous buffer system of Laemmli was different from the migration of the glycoproteins observed when a neutral buffer system was employed. The buffer system of Laemmli was also employed in the VOL. 14 (13, 18, 24, 32) . The MW for RS virus polypeptides determined with gel precipitates, as reported in the present paper, also differs slightly from the MW previously published. MWs for these polypeptides (shown in Fig. 5 , tracks b and c, in this report) fall into the same range as the MWs reported by Peeples and Levine (18) and by Ueba (24 
